JP2016528231A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528231A5
JP2016528231A5 JP2016531836A JP2016531836A JP2016528231A5 JP 2016528231 A5 JP2016528231 A5 JP 2016528231A5 JP 2016531836 A JP2016531836 A JP 2016531836A JP 2016531836 A JP2016531836 A JP 2016531836A JP 2016528231 A5 JP2016528231 A5 JP 2016528231A5
Authority
JP
Japan
Prior art keywords
cgrp
related peptide
calcitonin gene
seq
cys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016531836A
Other languages
English (en)
Japanese (ja)
Other versions
JP6538682B2 (ja
JP2016528231A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/048724 external-priority patent/WO2015017455A1/en
Publication of JP2016528231A publication Critical patent/JP2016528231A/ja
Publication of JP2016528231A5 publication Critical patent/JP2016528231A5/ja
Application granted granted Critical
Publication of JP6538682B2 publication Critical patent/JP6538682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016531836A 2013-07-30 2014-07-29 Ｃｇｒｐアゴニストペプチド Active JP6538682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361860244P 2013-07-30 2013-07-30
US61/860,244 2013-07-30
PCT/US2014/048724 WO2015017455A1 (en) 2013-07-30 2014-07-29 Cgrp agonist peptides

Publications (3)

Publication Number Publication Date
JP2016528231A JP2016528231A (ja) 2016-09-15
JP2016528231A5 true JP2016528231A5 (https=) 2017-09-07
JP6538682B2 JP6538682B2 (ja) 2019-07-03

Family

ID=51355665

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016531836A Active JP6538682B2 (ja) 2013-07-30 2014-07-29 Ｃｇｒｐアゴニストペプチド

Country Status (4)

Country Link
US (1) US9951115B2 (https=)
EP (1) EP3027644B1 (https=)
JP (1) JP6538682B2 (https=)
WO (1) WO2015017455A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016183479A1 (en) * 2015-05-13 2016-11-17 The Board Of Regents Of The University Of Oklahoma Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
EP3366286A1 (en) * 2017-02-22 2018-08-29 Johannes Keller Compounds for treating sepsis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021665A1 (en) * 1993-03-24 1994-09-29 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
ATE471340T1 (de) * 2004-02-11 2010-07-15 Amylin Pharmaceuticals Inc Peptide der amylin familie, verfahren zu deren herstellung und verwendung
CN101094689B (zh) 2004-11-01 2013-06-12 安米林药品有限责任公司 治疗肥胖以及肥胖相关疾病和病症的方法
CN102343084A (zh) * 2005-03-31 2012-02-08 安米林药品公司 用于治疗精神病和精神障碍的胰淀素和胰淀素激动剂
WO2007055743A2 (en) * 2005-11-01 2007-05-18 Amylin Pharmaceuticals, Inc. Treatment of obesity and related disorders
UA97707C2 (ru) 2007-11-14 2012-03-12 Амилин Фармасьютикалз, Инк. Способы лечения ожирения и заболеваний, расстройств, связанных с ожирением
WO2010107874A2 (en) 2009-03-17 2010-09-23 Amylin Pharmaceuticals, Inc. Methods for affecting body composition using amylin agonists
US20140249076A1 (en) * 2011-10-18 2014-09-04 Astrazeneca Pharmaceuticals Lp Amylin-calcitonin chimeric peptides conjugated to duration enhancing moieties
KR101855242B1 (ko) * 2012-01-26 2018-05-09 크리스토퍼 제이. 소레스 펩타이드 호르몬의 칼시토닌 cgrp 패밀리의 펩타이드 길항제 및 그의 용도

Similar Documents

Publication Publication Date Title
HRP20201353T1 (hr) Agonisti glukagonskog receptora
HRP20140616T1 (hr) Peptidni analog oksintomodulina
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
JP2017528419A5 (https=)
NZ771547A (en) Gip and glp-1 co-agonist compounds
PE20220938A1 (es) Compuestos agonistas de gipr
JP2015513318A5 (https=)
JP2013515057A5 (https=)
Ramos-Álvarez et al. A structure–function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists
JP2018135346A5 (https=)
HRP20190689T1 (hr) Muteini suznog lipokalina koji vežu il-4r alfa
JP2013515055A5 (https=)
JP2018515088A5 (https=)
NZ593833A (en) Extended recombinant polypeptides and compositions comprising same
AR064555A1 (es) Peptido wt1 restringido a hla-a*1101 y composicion farmaceutica que comprende el mismo
NZ621196A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
BRPI0812795C1 (pt) domínio variável único de imunoglobulina, antagonista tipo 1 do receptor tnfalfa, uso de um domínio ou antagonista de tnfr1, ácido nucleico recombinante, vetor, célula hospedeira, e, composição farmacêutica
EA201170337A1 (ru) Стабильная твердая композиция полипептидного агониста gc-c рецептора, приемлемая для перорального введения
EA201590525A1 (ru) Слитые белки для лечения метаболического синдрома
EA201000785A1 (ru) Композиции для доставки в легкие
JP2015517488A5 (https=)
JP2013543499A5 (https=)
HRP20150664T1 (hr) Antikancerogeni fuzijski protein
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
JP2017221201A5 (https=)